Huntsman (NYSE:HUN – Get Free Report) released its quarterly earnings results on Monday. The basic materials company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.18), Zacks reports. The firm had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.45 billion. Huntsman had a negative net margin of 1.99% and a negative return on equity of 0.03%.
Huntsman Price Performance
HUN stock traded up $0.26 during midday trading on Wednesday, reaching $18.06. The stock had a trading volume of 350,013 shares, compared to its average volume of 2,793,781. The company’s fifty day simple moving average is $17.52 and its 200 day simple moving average is $20.19. The company has a current ratio of 1.47, a quick ratio of 0.83 and a debt-to-equity ratio of 0.45. The company has a market cap of $3.12 billion, a price-to-earnings ratio of -26.10 and a beta of 0.95. Huntsman has a 52-week low of $15.67 and a 52-week high of $27.01.
Huntsman Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Friday, March 14th will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 5.54%. Huntsman’s payout ratio is currently -144.93%.
Analyst Ratings Changes
View Our Latest Stock Report on Huntsman
About Huntsman
Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products.
Further Reading
- Five stocks we like better than Huntsman
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
- Growth Stocks: What They Are, Examples and How to Invest
- Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?
Receive News & Ratings for Huntsman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsman and related companies with MarketBeat.com's FREE daily email newsletter.